Cargando…
Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes
BACKGROUND: Gestational diabetes (GDM) and milder gestational impaired glucose tolerance (GIGT) identify women at risk of developing type 2 diabetes and cardiovascular disease later in life. Accordingly, the postpartum years after gestational dysglycemia can provide insight into early events in the...
Autores principales: | Mehmood, Sadia, Ye, Chang, Connelly, Philip W., Hanley, Anthony J., Zinman, Bernard, Retnakaran, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176527/ https://www.ncbi.nlm.nih.gov/pubmed/30301460 http://dx.doi.org/10.1186/s12933-018-0776-y |
Ejemplares similares
-
Hepatic fat and glucose tolerance in women with recent gestational diabetes
por: Mehmood, Sadia, et al.
Publicado: (2018) -
Neighborhood walkability and risk of gestational diabetes
por: Kew, Simone, et al.
Publicado: (2020) -
Subtypes of gestational diabetes and future risk of pre-diabetes or diabetes
por: Retnakaran, Ravi, et al.
Publicado: (2021) -
Isolated Hyperglycemia at 1 Hour on Oral Glucose Tolerance Test in Pregnancy Resembles Gestational Diabetes Mellitus in Predicting Postpartum Metabolic Dysfunction
por: Retnakaran, Ravi, et al.
Publicado: (2008) -
Postpartum Metabolic Function in Women Delivering a Macrosomic Infant in the Absence of Gestational Diabetes Mellitus
por: Kew, Simone, et al.
Publicado: (2011)